|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.210 EGP | 0.00% |
|
-5.47% | +6.14% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 1.34 | 1.53 | 1.96 |
| Spread/Res. | -9.70% | -20.92% | -38.27% |
| Spread/Supp. | +2.54% | +14.15% | +16.12% |
| Support | 1.18 | 1.06 | 1.042 |
- Stock Market
- Stocks
- MCRO Stock
- Charts Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
